Digimeds to Optimize Adherence in Patients With Hepatitis C and Increased Risk for Nonadherence
Public ClinicalTrials.gov record NCT03164902. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of Wirelessly Observed Therapy to Optimize Adherence in Patients With Hepatitis C and Increased Risk for Nonadherence to Treatment
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study evaluates the ability of digital medicines, Proteus Discover, to promote adherence and thus achieving a cure for hepatitis C in patients at high risk for not adhering to their hepatitis therapy. In this single-arm, prospective study, subjects at high risk for nonadherence will be prescribed hepatitis C therapy that will be co-encapsulated with ingestible sensors (creating the digital medicine) by a pharmacy. Both the subject and the providers will have access to the ingestion adherence.
Study identification
- NCT ID
- NCT03164902
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 253 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 21, 2017 (Actual)
- Primary completion
- Apr 30, 2019 (Estimated)
- Completion
- Apr 30, 2019 (Estimated)
- Last update posted
- Dec 13, 2018
2017 – 2019
United States locations
- U.S. sites
- 16
- U.S. states
- 13
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama | Birmingham | Alabama | 35294 | — |
| Zuckerberg San Francisco General Hospital | San Francisco | California | 94110 | — |
| Peak Gastroenterology Associates | Colorado Springs | Colorado | 80907 | — |
| Denver Health | Denver | Colorado | 80204 | — |
| Providence Health System | Washington D.C. | District of Columbia | 20017 | — |
| Orlando Immunology Center | Orlando | Florida | 32803 | — |
| Apex Clinical Research | Tampa | Florida | 33612 | — |
| The Ruth M. Rothstein CORE Center | Chicago | Illinois | 60637 | — |
| Johns Hopkins University | Baltimore | Maryland | 21205 | — |
| The Research Institute | Springfield | Massachusetts | 01105 | — |
| Harper University Hospital | Detroit | Michigan | 48201 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Southwest Care Center | Santa Fe | New Mexico | 87502 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Harborview Medical Center | Seattle | Washington | 98104 | — |
| SSM Health Dean Medical Group | Madison | Wisconsin | 53713 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03164902, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 13, 2018 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03164902 live on ClinicalTrials.gov.